Cardinal Health (CAH) has entered into a binding letter of intent to extend its pharmaceutical distribution agreements with key customer CVS Health. The extension secures the partnership through mid-2032 and involves the continuation of the current scope of distribution services. In conjunction with the announcement, the company reaffirmed its financial guidance.
Key Details
- Agreement Term: The distribution agreements will be extended through June 30, 2032.
- Reaffirmed FY2027 Guidance: The company reaffirmed its fiscal year 2027 non-GAAP earnings per share (EPS) guidance range of $12.40 to $12.60.
- Reaffirmed Long-Term Outlook: Cardinal Health also reiterated its long-term non-GAAP EPS growth guidance of 12% to 14%.